» Articles » PMID: 14498756

Tadalafil

Overview
Journal Drugs
Specialty Pharmacology
Date 2003 Sep 23
PMID 14498756
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

black triangle Tadalafil is a selective phosphodiesterase type 5 inhibitor that is effective in men with mild-to-severe erectile dysfunction (ED), including those with diabetes mellitus. black triangle The improvement in the erectile function domain score on the International Index of Erectile Function (IIEF) and the percentage of sexual intercourse attempts marked by successful vaginal penetration and completion was significantly greater with on-demand (not more than once daily) tadalafil 10 or 20 mg than placebo in trials of 12 weeks' duration. Improvement in scores on other domains of the IIEF and the percentage of positive responses to a Global Assessment Question measuring erection improvement were also significantly greater with on-demand tadalafil than placebo. black triangle The adverse events associated with tadalafil were generally mild to moderate and decreased in frequency with continued administration. The most commonly reported adverse events were headache and dyspepsia. The incidence of cardiovascular adverse events was not significantly different in tadalafil or placebo recipients.

Citing Articles

Prospective, randomized, placebo-controlled, two-arm study to evaluate the efficacy of coadministration of garlic as a hydrogen sulfide donor and tadalafil in patients with erectile dysfunction not responding to tadalafil alone - A pilot study.

Bhat G, Shastry A Indian J Pharmacol. 2024; 56(4):242-247.

PMID: 39250620 PMC: 11483042. DOI: 10.4103/ijp.ijp_310_23.


Evaluation of efficacy and safety profile of tadalafil 5 mg daily dose in the tablet form versus oral dispersible film in men with mild-to-moderate erectile dysfunction: a comparative placebo-controlled study.

Motawi A, GamalEl Din S, Meatmed E, Fahmy I Int Urol Nephrol. 2024; 56(8):2531-2537.

PMID: 38433177 PMC: 11266281. DOI: 10.1007/s11255-024-04003-x.


Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride.

Villapalos-Garcia G, Zubiaur P, Marian-Revilla C, Soria-Chacartegui P, Navares-Gomez M, Mejia-Abril G J Pers Med. 2023; 13(11).

PMID: 38003881 PMC: 10672114. DOI: 10.3390/jpm13111566.


Carotid artery intima media thickness can predict the response to phosphodiesterase 5 inhibitors in patients with moderate erectile dysfunction.

Kilic M, Caglayan V, Sambel M, Erdogan A, Onen E, Kurtoglu U Sex Med. 2023; 11(3):qfad042.

PMID: 37529683 PMC: 10388700. DOI: 10.1093/sexmed/qfad042.


Effects of tadalafil on sexual behavior of male rats induced by chronic unpredictable mild stress.

Wang H, Liu X, Zhang Z, Han Z, Jiang Y, Qiao Y Sex Med. 2023; 11(2):qfad019.

PMID: 37256219 PMC: 10225468. DOI: 10.1093/sexmed/qfad019.


References
1.
Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R . Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology. 2003; 62(1):121-5; discussion 125-6. DOI: 10.1016/s0090-4295(03)00359-5. View

2.
Blanker M, Bosch J, Groeneveld F, Bohnen A, Prins A, Thomas S . Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology. 2001; 57(4):763-8. DOI: 10.1016/s0090-4295(00)01091-8. View

3.
Porst H . IC351 (tadalafil, Cialis): update on clinical experience. Int J Impot Res. 2002; 14 Suppl 1:S57-64. DOI: 10.1038/sj.ijir.3900807. View

4.
Marumo K, Nakashima J, Murai M . Age-related prevalence of erectile dysfunction in Japan: assessment by the International Index of Erectile Function. Int J Urol. 2001; 8(2):53-9. DOI: 10.1046/j.1442-2042.2001.00258.x. View

5.
de Tejada I, Anglin G, Knight J, Emmick J . Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care. 2002; 25(12):2159-64. DOI: 10.2337/diacare.25.12.2159. View